Why Can’t mTOR Inhibitors Kill Cancer?

News   Oct 06, 2017 | Original story from UT Health San Antonio

 
Why Can’t mTOR Inhibitors Kill Cancer?

Mitochondrial elongation, induced by mTOR-inhibiting drugs, contributes to cell survival. Credit: Facility for Electron Microscopy Research/McGill University Department of Anatomy and Cell Biology.

 
 
 

RELATED ARTICLES

Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment

News

Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.

READ MORE

Mechanism Behind Inflammatory Response to Cytoplasmic DNA Identified

News

A team led by LMU‘s Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in mice.

READ MORE

Psychosocial Factors May Influence Cellular Age Of Pregnant Women

News

Pregnant women who had low socioeconomic status during childhood and who have poor family social support appear to prematurely age on a cellular level, potentially raising the risk for complications, a new study has found.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE